According to an article in DiaTribe, researchers have suggested that the new drugs developed to help people with Type 2 diabetes to lose weight, lower glucose, and prevent complications could also provide major benefits for people with Type 1 diabetes.
Like those with Type 2 diabetes, people with Type 1 deal with high glucose levels and risk of complications and some may also struggle with weight management, especially if they are older.
New medications approved only for those with Type 2 diabetes – like GLP-1 receptor agonists, SGLT-2 inhibitors, and the new “dual” GIP/GLP-1 receptor agonist Mounjaro (tirzepatide) – have been shown to help people lower glucose levels, lose weight, and protect against complications like heart and kidney disease. Accordingly, experts at the European Association for the Study of Diabetes (EASD) 2022 meeting in Stockholm are suggesting that combinations of these therapies could also benefit people with Type 1 diabetes.
To read more, CLICK HERE.
